Market Cap $116.8M
!


Corporate Spotlight
Paradigm Biopharmaceuticals Limited (ASX:PAR) is an ASX-listed late-stage drug development company focused on delivering new therapies to address unmet medical needs.
View the full Corporate Spotlight
PAR - close to a cure for osteoarthritis?
Last update - 12.03pm 23/06/2025 (20 minute delay)
?
Day | ||||||||
---|---|---|---|---|---|---|---|---|
Open | 30.0¢ | Day High | 30.5¢ | Day Low | 29.5¢ | |||
Daily Volume | 123220 |
Bids | Sellers | |||||
---|---|---|---|---|---|---|
Number | Price | Volume | Number | Price | Volume | |
5 | 29.5¢ | 51893 | 2 | 30.5¢ | 12273 |
Directors & Senior Management
Mr. Paul Rennie | Executive Chairman of the Board, Managing Director |
Ms. Abby Macnish Niven | Chief Financial Officer, Company Secretary |
Mr. Matthew James Fry | Non-Executive Director |
Mr. Amos Meltzer | Non-Executive Independent Director |
Data source: Refinitiv